Riskpilot← Back to searchSign inGet full accessCOLOSSEUMKLINIKKEN AS
ASActiveOrg 922686580Gudes Gate 1, 1530 MossDental practice care activities · NACE 8623Est. 20194 employees
Revenue 2023
NOK 9,3M
+15% vs 2022
EBITDA margin
31.2%
+32% vs 2022
Equity ratio
6.7%
Financial strength
Net profit 2023
NOK 2,2M
+33% vs 2022
| Revenue | NOK 9,3M | +15% |
| EBITDA | NOK 2,9M | +32% |
| Net profit | NOK 2,2M | +33% |
| Total assets | NOK 3,7M | +153% |
| Equity | NOK 245K | +616% |
| Employees | 4 | — |
Legal name
COLOSSEUMKLINIKKEN AS
Org number
922686580
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
29. april 2019
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Tannlegepraksis.
Address
Gudes Gate 1, 1530 Moss
Phone
+4769252605
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 3 378 | 3 749 | 4 321 | 8 052 | 9 252 |
| Staff expenses | −1 101 | −1 483 | −1 264 | −607 | −610 |
| EBITDA | 1 207 | 1 296 | 1 992 | 2 186 | 2 886 |
| Depreciation & amort. | −0 | −0 | −0 | −45 | −48 |
| EBIT | 1 207 | 1 296 | 1 992 | 2 141 | 2 838 |
| Net financials | −0 | −2 | 0 | −1 | −3 |
| Profit before tax | 1 207 | 1 294 | 1 992 | 2 140 | 2 835 |
| Tax | 267 | 286 | 438 | 474 | 624 |
| Net profit | 940 | 1 008 | 1 554 | 1 666 | 2 211 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 369 | 2 499 | 2 322 | 1 451 | 3 676 |
| Equity | 876 | 135 | 338 | 34 | 245 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 493 | 2 363 | 1 982 | 1 415 | 3 431 |
| Total debt | 493 | 2 364 | 1 983 | 1 417 | 3 431 |
EBITDA margin
31.2%
This company
15.8%
Market median
+97% vs market
20192023
Equity ratio
6.7%
This company
38.2%
Market median
-82% vs market
20192023
Return on equity
901.9%
This company
18.4%
Market median
+4802% vs market
20192023
Net profit margin
23.9%
This company
8.1%
Market median
+195% vs market
20192023
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20192023
Debt / equity
14.00×
This company
0.62×
Market median
-2158% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ME Chief Executive Officer | Chief Executive Officer | 2024 |
JS Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Atle Trondsen As
COLOSSEUMKLINIKKEN AS Board members of COLOSSEUMKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Evy Maria Grundström | Chief Executive Officer | 0 companies |
| Jon-Audun Solem | Chief Executive Officer | 0 companies |
| Atle Trondsen | Chairman | 0 companies |
| Pål Mørkved | Chairman | 0 companies |